Literature DB >> 2605090

Estimation of regional metabolism and production of angiotensins in hypertensive subjects.

M A Schalekamp1, P J Admiraal, F H Derkx.   

Abstract

1. We attempted to collect information on the metabolism and production of angiotensins (ANG) in different vascular beds in humans by constant i.v. infusion of mono-iodinated [125I]-ANG I into subjects with essential hypertension, at the time of renal vein catheterization as part of the diagnostic work-up for renovascular hypertension. 2. Blood samples were taken from the aorta and the renal, antecubital, femoral and hepatic veins. ANG I, ANG II, [125I]-ANG I and [125I]-ANG II were extracted from plasma, separated by h.p.l.c. and quantitated by radio-immunoassay or gamma counting. 3. Our studies so far are restricted to subjects on captopril 50 mg twice daily. Under ACE inhibition (4-6 h after dosing of captopril) no differences in elimination half-life and regional extraction were found between infused [125I]-ANG and unlabelled ANG I. Extraction of arterially delivered [125I]-ANG I was 80% in the kidney, 45% in the forearm, 58% in the leg and 95% in the hepato-mesenteric vascular bed. 4. Measurements of arterial and venous [125I]-ANG II levels indicated that [125I]-ANG I-II conversion had occurred in the cardio-pulmonary vascular bed. 5. ANG I production in the hepato-mesenteric region could be largely accounted for by the renin activity of circulating plasma, but in kidney and limbs only 20-30% of regionally produced ANG I could be accounted for by plasma renin activity. 6. Thus, a major fraction of regionally produced ANG I appears to be formed locally, i.e. not in circulating plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605090      PMCID: PMC1379849          DOI: 10.1111/j.1365-2125.1989.tb03586.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

Review 1.  Significance of the vascular renin-angiotensin pathway.

Authors:  V J Dzau
Journal:  Hypertension       Date:  1986-07       Impact factor: 10.190

2.  Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.

Authors:  J Nussberger; D B Brunner; B Waeber; H R Brunner
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

3.  Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma.

Authors:  F H Derkx; G J Wenting; A J Man in 't Veld; R P Verhoeven; M A Schalekamp
Journal:  Clin Sci Mol Med       Date:  1978-05

Review 4.  Arterial wall or plasma renin in hypertension?

Authors:  J D Swales
Journal:  Clin Sci (Lond)       Date:  1979-04       Impact factor: 6.124

5.  An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.

Authors:  K Poulsen; J Jorgensen
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

6.  Vascular renin-like activity and blood pressure maintenance in the rat. Studies of the effect of changes in sodium balance, hypertension and nephrectomy.

Authors:  H Thurston; J D Swales; R F Bing; B C Hurst; E S Marks
Journal:  Hypertension       Date:  1979 Nov-Dec       Impact factor: 10.190

7.  Angiotensin I, II, and III in sheep. A model of angiotensin production and metabolism.

Authors:  D T Fei; B A Scoggins; G W Tregear; J P Coghlan
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

8.  Renal blood flow, circulation times and vascular volume in normal man measured by the intraarterial injection--external counting technique.

Authors:  J Ladefoged; F Pedersen
Journal:  Acta Physiol Scand       Date:  1967-03

9.  Effects of locally formed angiotensin II on renal hemodynamics.

Authors:  L G Navar; L Rosivall; P K Carmines; S Oparil
Journal:  Fed Proc       Date:  1986-04

10.  Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog.

Authors:  L Rosivall; D F Rinder; J Champion; M C Khosla; L G Navar; S Oparil
Journal:  Am J Physiol       Date:  1983-09
View more
  3 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.

Authors:  F Lembeck; T Griesbacher; M Eckhardt
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.

Authors:  J R Wade; P A Meredith; D M Hughes; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.